These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 4686378)
1. Effect of o,p'DDD on human adrenal steroid 11 beta-hydroxylation activity. Brown RD; Nicholson WE; Chick WT; Strott CA J Clin Endocrinol Metab; 1973 Apr; 36(4):730-3. PubMed ID: 4686378 [No Abstract] [Full Text] [Related]
2. Treatment of Cushing's sundrome in the dog with an adrenocorticolytic agent (o,p'DDD). Schechter RD; Stabenfeldt GH; Gribble DH; Ling GV J Am Vet Med Assoc; 1973 Apr; 162(8):629-39. PubMed ID: 4697358 [No Abstract] [Full Text] [Related]
3. Rapidly progressing high o,p'DDD doses shorten the time required to reach the therapeutic threshold with an acceptable tolerance: preliminary results. Faggiano A; Leboulleux S; Young J; Schlumberger M; Baudin E Clin Endocrinol (Oxf); 2006 Jan; 64(1):110-3. PubMed ID: 16402938 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Cushing's disease. Correction of hypercortisolism by o,p'DDD without induction of aldosterone deficiency. Temple TE; Jones DJ; Liddle GW; Dexter RN N Engl J Med; 1969 Oct; 281(15):801-5. PubMed ID: 4309238 [No Abstract] [Full Text] [Related]
5. A simplified metyrapone test with determination of plasma ll-deoxycortisol (Metyrapone test with plasma S). Meikle AW; Jubiz W; Hutchings MP; West CD; Tyler FH J Clin Endocrinol Metab; 1969 Jul; 29(7):985-7. PubMed ID: 5793454 [No Abstract] [Full Text] [Related]
6. Management of Cushing's syndrome due to ectopic adrenocorticotropin secretion with 1,ortho-1, para'-dichloro-diphenyl-dichloro-ethane: findings in 23 patients from a single center. Donadille B; Groussin L; Waintrop C; Abbas H; Tenenbaum F; Dugué MA; Coste J; Bertagna X; Bertherat J J Clin Endocrinol Metab; 2010 Feb; 95(2):537-44. PubMed ID: 20061433 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases. Luton JP; Mahoudeau JA; Bouchard P; Thieblot P; Hautecouverture M; Simon D; Laudat MH; Touitou Y; Bricaire H N Engl J Med; 1979 Mar; 300(9):459-64. PubMed ID: 215912 [TBL] [Abstract][Full Text] [Related]
8. Effect of o,p'-DDD on cortisol secretory pattern in Cushing's syndrome. Hellman L; Weitzman ED; Roffwarg H; Fukushima DK; Yoshida K; Zumoff B; Gallagher TF J Clin Endocrinol Metab; 1970 Aug; 31(2):227-30. PubMed ID: 4316529 [No Abstract] [Full Text] [Related]
9. Plasma desoxycorticosterone levels in man with simultaneous measurement of aldosterone, corticosterone, cortisol and 11-deoxycortisol. Oddie CJ; Coghlan JP; Scoggins BA J Clin Endocrinol Metab; 1972 Jun; 34(6):1039-54. PubMed ID: 4336456 [No Abstract] [Full Text] [Related]
10. [Determination of steroid hormones by means of protein competition. General principles]. Fonzo D; Lauro R; Dogliotti L; Paschero G Minerva Med; 1973 Sep; 64(64):3322-31. PubMed ID: 4774225 [No Abstract] [Full Text] [Related]
11. [Determination of plasma transcortin in cases of different endocrine diseases]. Burger A; Laudat P; Bricaire H Acta Endocrinol (Copenh); 1970 Aug; 64(4):602-9. PubMed ID: 5468661 [No Abstract] [Full Text] [Related]
12. Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemia. Maher VM; Trainer PJ; Scoppola A; Anderson JV; Thompson GR; Besser GM Q J Med; 1992 Sep; 84(305):671-9. PubMed ID: 1480741 [TBL] [Abstract][Full Text] [Related]
13. Sex differences in corticosteroids in man. Schöneshöfer M; Wagner GG J Clin Endocrinol Metab; 1977 Oct; 45(4):814-7. PubMed ID: 914983 [TBL] [Abstract][Full Text] [Related]
14. [Cushing's syndrome]. Geyer G Ann N Y Acad Sci; 1973 Jun; 214():614-9. PubMed ID: 4593436 [No Abstract] [Full Text] [Related]